SUCLA2 and neoplasm: Differential changes in expression have not been observed [19], while Tong et al. found that GLS is highly expressed in pancreatic ductal adenocarcinoma (PDAC) and demonstrated that SUCLA2-coupled regulated GLS succinylation can counteract oxidative stress in tumor cells [20].